---
title: 'Sustained response following BTK inhibitors based treatment in HIV-related
  primary central nervous system lymphoma: case report'
date: '2023-08-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37644480/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1T5FW5K6kI7Ui-YFfm6b8NuT1rAqMfZcYcvuOELhU7ZdLYMMmI&fc=20220727230845&ff=20230830180526&v=2.17.9.post6+86293ac
source: (yan,xiaojing[Author]) AND (China medical university[Affiliation])
description: 'CONCLUSIONS: This report highlights the safety and effectiveness of
  BTK inhibitors, as well as lenalidomide and PD-1 inhibitor in HIV-related PCNSL
  patients. Both the new therapeutic approaches and a multidisciplinary team authentically
  contributed to improved survival outcome among HIV-positive PCNSL ...'
disable_comments: true
---
CONCLUSIONS: This report highlights the safety and effectiveness of BTK inhibitors, as well as lenalidomide and PD-1 inhibitor in HIV-related PCNSL patients. Both the new therapeutic approaches and a multidisciplinary team authentically contributed to improved survival outcome among HIV-positive PCNSL ...